| Literature DB >> 32984248 |
Arianna Rubin Means1, Anjuli D Wagner1, Eli Kern2, Laura P Newman1,3, Bryan J Weiner1,4.
Abstract
The COVID-19 pandemic continues to expand globally, requiring massive public health responses from national and local governments. These bodies have taken heterogeneous approaches to their responses, including when and how to introduce and enforce evidence-based interventions-such as social distancing, hand-washing, personal protective equipment (PPE), and testing. In this commentary, we reflect on opportunities for implementation science to contribute meaningfully to the COVID-19 pandemic response. We reflect backwards on missed opportunities in emergency preparedness planning, using the example of PPE stockpiling and supply management; this planning could have been strengthened through process mapping with consensus-building, microplanning with simulation, and stakeholder engagement. We propose current opportunities for action, focusing on enhancing the adoption, fidelity, and sustainment of hand washing and social distancing; we can combine qualitative data, policy analysis, and dissemination science to inform agile and rapid adjustment to social marketing strategies to enhance their penetration. We look to future opportunities to enhance the integration of new evidence in decision-making, focusing on serologic and virologic testing systems; we can leverage simulation and other systems engineering modeling to identify ideal system structures. Finally, we discuss the ways in which the COVID-19 pandemic challenges implementation science to become more rapid, rigorous, and nimble in its approach, and integrate with public health practice. In summary, we articulate the ways in which implementation science can inform, and be informed by, the COVID-19 pandemic, looking backwards, proposing actions for the moment, and approaches for the future.Entities:
Keywords: COVID-19; SARS-CoV-2; implementation science; novel coronavirus; public health response
Year: 2020 PMID: 32984248 PMCID: PMC7493639 DOI: 10.3389/fpubh.2020.00462
Source DB: PubMed Journal: Front Public Health ISSN: 2296-2565
Operationalizing Proctor implementation outcomes for COVID-19.
| Acceptability | Perception among implementation stakeholders that a given treatment, service, practice, or innovation is agreeable, palatable, or satisfactory | Individual consumer | Public agreement and personal values aligning with social distancing policies | Race, class, and ability to social distance | Public trust and uptake of policies, community transmission reduction |
| Adoption | Intention, initial decision, or action to try or employ an innovation or evidence-based practice | Individual provider | Attempted use of national testing guidelines | Clarity of guidelines, test kits available | Identification of positive cases and linkage to clinical management |
| Appropriateness | Perceived fit, relevance, or compatibility of the innovation or evidence based practice for a given practice setting, provider, or consumer; and/or perceived fit of the innovation to address a particular issue or problem | Individual consumer | Compatibility between mask wearing and public life | Stigma associated with mask use, clarity of government guidance | Community transmission reduction |
| Feasibility | Extent to which a new treatment, or an innovation, can be successfully used or carried out within a given agency or setting | Individual provider | Extent to which health workers can accurately apply rapidly evolving virologic testing guidelines | Clarity of guidelines, effective management support, test kit, and PPE resource availability | Efficient test kit allocation to maximize identification of cases and link to clinical management, ability for health workers to return to work to perform clinical management for patients |
| Fidelity | Degree to which an intervention was implemented as it was prescribed in the original protocol or as it was intended by the program developers | Individual provider | Public health practitioners implement supply chain for test kits, specimens, and case follow-up activities as designed | Availability of necessary resources, appropriate alignment between tasks and tasked personnel, effective communication that accounts for practitioner input | Reduction in community transmission |
| Implementation cost | The cost impact of an implementation effort | Provider or providing institution | Change in resource use at health facilities associated with social distancing | Political and economic pressure not to introduce “stay at home” restrictions | Increased resources for acutely ill (ex. ventilators), and reduction in morbidity and mortality |
| Penetration | Integration of a practice within a service setting and its subsystems | Organization or setting | Integrating processes (such as microplanning) for allocating resources across institutions and government offices, resulting in a harmonized approach to pandemic preparedness with multi-level consensus regarding leadership, communication, and management structures to be activated in an emergency | Leadership engagement, formal interorganizational networks, new resources made available for pandemic preparedness | Reduced community transmission, reduced hospital transmission |
| Sustainability | Extent to which a newly implemented treatment is maintained or institutionalized within a service setting's ongoing, stable operations | Administrators | Degree to which hospital leadership and government leadership do or do not maintain free coronavirus testing policies after the peak of the epidemic | Coordination between policymaker and scientists, resource availability | Risk of future case surges |
Key implementation questions, outcomes, methods, and strategies for evidence-based COVID-19 interventions, at different stages of the pandemic.
| Reflecting backward: opportunities for future emergency preparedness process/systems improvement | PPE | How can systems for stockpiling and subsequently distributing PPE be more automated and less reactive? | Sustainability | Process mapping ( | • Purposefully re-examine implementation (e.g., understand current processes and adjust as necessary) |
| PPE | How can we ensure that every health worker has access to, and appropriately dons, PPE? | Adoption, acceptability, fidelity | Stakeholder engagement, social marketing and education ( | • Develop and distribute educational materials (e.g., social media videos of hand washing techniques, open source patterns for crafting masks on public health websites) | |
| Intensive care management | How can we rapidly and efficiently deploy a massive volunteer health force (e.g., doctors and nurses in NYC, or a public health corps)? | Feasibility, penetration | Process mapping, stakeholder engagement, optimization modeling ( | • Role revision and liability laws (e.g., legislation to allow non-ICU health care workers to serve in certain capacities in times of pandemic) | |
| Intensive care management | How can we ensure that BIPOC communities are receiving equitable screening, testing, and intensive care management? How do we proactively monitor whether tailored responses are equitable for marginalized communities and change our approaches when data reveals inequitable responses? | Adoption, fidelity | Surveillance and data systems ( | • Educational meetings and outreach visits (e.g., educating health workers on root causes of inequity, identifying, and rectifying implicit biases) | |
| Intensive care management | How can we meet the infrastructure needs required to accommodate patient surges? | Cost, feasibility, penetration | Economic evaluation, optimization modeling | • Change physical structure or equipment (e.g., shift elective areas of hospital into COVID-19 specific wards, convert stadiums and tents into hospitals) | |
| Acting now: enhancing adoption, fidelity, and sustainment of behavioral public health interventions | Social distancing | What kinds of approaches are most effective for increasing fidelity to social distancing? How do we measure and use context to improve transferability of early learnings? | Fidelity | Social marketing, rapid ethnography to understand implementation contexts ( | • Identify early adopters, inform local leaders, Mandate change (e.g., regional policies) |
| Social distancing | Are there small tweaks to social distancing policies that improve their effectiveness by making it easier to comply with and sustain? | Acceptability, fidelity, sustainability | Policy analysis, rapid cycle quality improvement | • Promote adaptability and tailor strategies (e.g., retain core element of 6 feet apart distance, but tailor guidance to allow walking 6 feet apart in pairs) | |
| Social distancing | How does community fidelity to social distancing impact epidemic duration? | Acceptability, fidelity | Qualitative data collection and rapid analysis ( | • Use data experts (e.g., utilize passive data, like GPS mobility data aggregated by Google, to inform fidelity near real-time with regional specificity) | |
| Community behavior change | How does public trust of government officials impact community level compliance with new COVID-19 policies? | Adoption, appropriateness, Fidelity | System dynamics modeling ( | • Educational meetings and outreach visits (e.g., “Town Hall” style meetings with public officials and public health institutions) | |
| Community behavior change | How can marginalized communities—especially incarcerated or detained persons, persons experiencing homelessness—be enabled to participate in social distancing and other community behavior change activities? | Adoption, appropriateness, fidelity | Policy analysis, stakeholder engagement | • Change physical structure or equipment (e.g., provide free and stable housing, release incarcerated persons from prisons and jails and detention centers) | |
| Hand washing and Mask wearing in public spaces | How can we increase coverage of non-medical mask usage in public spaces? Which communication strategies regarding proper hand washing and mask use result in high accuracy and behavioral maintenance on the individual level? | Acceptability, adoption, fidelity, sustainability | Social marketing | • Use mass media, Start a dissemination organization, Develop and distribute educational materials (e.g., social media videos of hand washing techniques, open source patterns for crafting masks on public health websites) | |
| Cross-cutting | How do we prioritize which policies to deploy (e.g., improve social distancing, mask usage, contact tracing and quarantine, virologic testing coverage, etc.)? How do these decisions change for a resource-limited setting? | Cost, adoption, penetration, sustainability | Simulation models ( | • Conduct local needs assessment (e.g., differentiate policies that are engendering targeted behavior changes, by region) | |
| Moving forward: integrating new evidence into decision-making and programming | Testing | How can laboratory testing networks be optimally designed to receive samples within a geographic network and quickly share results back to providers and individuals? How can we ensure that turnaround time is not only fast, but equitable in reaching the multiple, diverse communities who are marginalized? | Appropriateness (practicability), feasibility | Simulation modeling (e.g., queuing, discrete event simulation), surveillance and data systems | • Model and simulate change, change service sites (e.g., consider hub-and-spoke model, disaggregate data sources and model outputs to enable assessments of inequity and prioritize equity in modeled scenarios) |
| Testing | What is the most efficient approach to conducting drive-through sample collection for testing? What structural tweaks can be made to this infrastructure to equitably serve populations with diversity in neighborhood, income, wealth, and access to cars? | Appropriateness (practicability), feasibility | Operations research ( | • Rapid iterative tests of change, stage implementation scale up, purposely re-examine the implementation, audit and feedback, develop and organize quality monitoring systems (e.g., continue to assess time spent waiting for sample collection, turnaround time, flow of cars through system and bottlenecks, assess metrics disaggregated by neighborhood and socio-economic status and optimize to ensure equity for each group) | |
| Testing | How can we overcome structural barriers to testing at the individual and provider levels? How are structural barriers magnified for marginalized communities, including BIPOC, undocumented persons, incarcerated persons, and persons experiencing homelessness? How can structural barriers be mitigated for diverse communities? | Adoption | Policy analysis, costing and cost-effectiveness, Social marketing | • Alter patient fee structure (e.g., insurance, copays, etc.) | |
| Testing | How can clinicians know who to test and how often in a setting of rapidly evolving guidance on test eligibility? | Adoption, fidelity | Policy analysis and leadership engagement, quality improvement | • Remind clinicians and use data warehousing techniques (e.g., integrate symptom check and relevant questions in integrated EMR with automatic flag for test eligibility and prompt to order, harmonize EMR platforms across hospital networks) | |
| Case contact tracing | How can we staff the aggressively high coverage of contact tracing required to relax social distancing policies within a geographic area? | Cost, feasibility, penetration | Cost-effectiveness analysis, policy analysis, Stakeholder mapping and engagement | • Shadow other experts, revise professional roles (e.g., allow expanded lay workforce with training to do contact tracing) | |
| Case contact tracing | How can a public health response acknowledge the historic injustices that leave diverse marginalized communities differently and disproportionately affected, and adapt their intensive contact tracing approach to be compatible with varied trust in public systems and concerns about privacy? | Acceptability | Social marketing, qualitative data, dissemination science ( | • Intervene with patients to enhance uptake and adherence, involve patients and family members, Obtain and use patient and family feedback, prepare patients to be active participants, local consensus discussions (e.g., develop communication strategies in partnership with patient populations) | |
| Future vaccine | In the case of initially limited vaccine availability, how do we prioritize and operationalize vaccination for the most vulnerable? How does that approach and system shift as supplies become more readily available? | Appropriateness (practicability), feasibility, penetration | System dynamics modeling, stakeholder engagement, process mapping | • Assess for readiness and identify barriers and facilitators, facilitate relay of clinical data to providers (e.g., to ensure that standardized approaches are used to identify and prioritize patients) | |
| Future medication for prophylaxis or treatment | When efficacious medications have been identified for broad prevention, post-exposure prophylaxis, and case treatment, how do we update guidelines for use and broadly distribute? | Adoption, penetration | Social marketing, qualitative data, dissemination science | • Provide clinical supervision, provide ongoing consultation | |
| Reducing usage of medications/interventions that are not evidence-based | How can we inhibit or reverse adoption of value-neutral or negative interventions? | De-implementation, adoption | Social marketing, qualitative data, dissemination science | • Remind clinicians and use data warehousing techniques (e.g., integrate diagnosis and treatment check in EMR with automatic flag for test eligibility and prompt to order) |